← All diseases Infectious diseases

Chronic hepatitis C

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest quality evidence only (79)Meta-analysis (20)Treatment guideline (4)Phase 3 study (27)Randomized trial (14)Systematic review (14)Clinical trial (677)Review article (146)Early study (phase 1 or 2) (11)Case report (85)Laboratory or animal study (8)Commentary or editorial (53)Retracted publication (2) Studies currently recruiting participants only (15)

Filter

Publications and studies (1942)

• Label-free test kit for D-amino acid analysis by 1,4-benzenediboronic-acid-induced aggregation of gold nanoparticles. (2020/07/09) ♡
• Predictors of linkage to care for a nontargeted emergency department hepatitis C screening program. (2020/07/01) ♡
• Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3-11 Years with Hepatitis C Genotype 1a. (2020/07/01) ♡
• Discovery of Hepatitis C Virus: 2020 Nobel Prize in Medicine. (2020/07/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Global hepatitis C elimination: history, evolution, revolutionary changes and barriers to overcome. (2020/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Incidental case of primary renal lymphoma (PRL) in a patient with chronic hepatitis C infection. Report of a rare case. (2020/07/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Effect of L-Carnitine Supplementation on Lipid Profiles of Patients with Liver Disease: A Systematic Review and Meta-Analysis. (2020/06/30) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Safety, efficacy and cost of two direct-acting antiviral regimens: A comparative study in chronic hepatitis C Egyptian patients. (2020/06/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression. (2020/06/01) ♡
• Treatment of Hepatitis C: A New Paradigm toward Viral Eradication. (2020/06/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis. (2020/05/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection. (2020/05/01) ♡
• NS5A-P32 Deletion in Hepatitis C Genotype 1b Infection is the Most Refractory Treatment-Mediated Amino Acid Change Exhibiting Resistance to all NS5A Inhibitors. (2020/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Overview of hepatitis C infection, molecular biology, and new treatment. (2020/05/01) ♡
• Nailfold capillaroscopic changes in patients with chronic viral hepatitis. (2020/05/01) ♡
• Predictors of Perioperative Vancouver B Periprosthetic Femoral Fractures Associated With the Direct Anterior Approach to Total Hip Arthroplasty. (2020/05/01) ♡
• Sofosbuvir-Velpatasvir Fixed Drug Combination for the Treatment of Chronic Hepatitis C Infection in Patients With End-Stage Renal Disease and Kidney Transplantation. (2020/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Natural products for the management of the hepatitis C virus: a biochemical review. (2020/05/01) ♡
• Association of seasonality and serum albumin concentration with vitamin D deficiency in subjects with chronic hepatitis C infection living in a sunny country. (2020/05/01) ♡
• Comparison of Recommendations for Treatment of Chronic Hepatitis C Virus Infection in Children and Adolescents: A Position Paper of the Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition. (2020/05/01) ♡
• Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus. (2020/04/27) ♡
• The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV-HCV Coinfection. (2020/04/24) ♡
• Vital Signs: Newly Reported Acute and Chronic Hepatitis C Cases - United States, 2009-2018. (2020/04/10) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir. (2020/04/02) ♡
• Incidence and predictors of direct-acting antiviral treatment failure in Turkish patients with chronic hepatitis C genotype 1b infection. (2020/04/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. High risk of hepatitis B virus reactivation among patients treated with direct-acting antivirals and coinfected with HCV and HIV. (2020/04/01) ♡
• Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia. (2020/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Three Children Treated with Direct-acting Antivirals for Chronic Hepatitis C Virus Genotype 1b Infection. (2020/04/01) ♡
• Transient elastography in DAA era. Relation between post-SVR LSM and histology. (2020/04/01) ♡
• Sofosbuvir-containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairment. (2020/04/01) ♡
• Does SEN-V and other non-A-E hepatotropic viruses contribute to the development and progression of non-alcoholic fatty liver disease? (2020/04/01) ♡
• Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort. (2020/04/01) ♡
• Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma. (2020/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals. (2020/04/01) ♡
• Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017. (2020/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Efficacy of 8 Weeks Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 4 in Children Aged 4-10 Years. (2020/04/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Chronic hepatitis C virus infection and genitourinary cancers: A case-control study. (2020/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: Implications for therapeutic monitoring and personalized therapy. (2020/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action. (2020/03/01) ♡
• Surveillance and impact of occult hepatitis B virus, SEN virus, and torque teno virus in Egyptian hemodialysis patients with chronic hepatitis C virus infection. (2020/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: "Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action". (2020/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Commentary on Barré et al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era. (2020/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV. (2020/03/01) ♡
• Genotype 1 and 3 Response to Velpatasvir and Sofosbuvir in Chronic Hepatitis C in the Kashmiri Population: An Observational Study. (2020/03/01) ♡
• Epidemiology of chronic liver diseases in the USA in the past three decades. (2020/03/01) ♡
• Liver Health Literacy and Health Status Among Adults With Hepatitis C: Implications for the Nursing Profession as Part of the 2030 Global Elimination Goal. (2020/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)". (2020/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Spontaneous regression of hepatocellular carcinoma: myth or reality? (2020/02/10) ♡
• Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C Patients. (2020/02/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Securing sustainable funding for viral hepatitis elimination plans. (2020/02/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.